32 results
8-K
EX-3.1
SEEL
Seelos Therapeutics Inc
10 Jan 24
Material Modifications to Rights of Security Holders
4:16pm
8-K
EX-3.1
SEEL
Seelos Therapeutics Inc
28 Nov 23
Material Modifications to Rights of Security Holders
9:00am
8-K
EX-3.1
SEEL
Seelos Therapeutics Inc
19 May 23
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-3.1
SEEL
Seelos Therapeutics Inc
24 Mar 23
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
EX-3.1
SEEL
Seelos Therapeutics Inc
21 May 21
Material Modifications to Rights of Security Holders
4:29pm
8-K/A
EX-3.1
pbkpk73gyz7
21 May 20
Material Modifications to Rights of Security Holders
12:00am
8-K
EX-3.1
joj04fkw5
19 May 20
Material Modifications to Rights of Security Holders
8:30am
8-K
EX-3.2
br43tam697
24 Jan 19
Completion of Acquisition or Disposition of Assets
8:05am
8-K
EX-3.1
2mp14
24 Jan 19
Completion of Acquisition or Disposition of Assets
8:05am
8-K
EX-3.3
2qhie9cwqnhh
24 Jan 19
Completion of Acquisition or Disposition of Assets
8:05am
8-K
EX-3.1
h7wx96ux f7lm7vjy98p
16 Oct 18
Entry into a Material Definitive Agreement
8:57pm
425
EX-3.1
c5u6h8d b6r
16 Oct 18
Business combination disclosure
8:56pm
8-K
EX-3.1
17k7dtlsh7
25 Oct 16
Apricus Biosciences Announces 1-for-10 Reverse Stock Split
12:00am
8-K
EX-3.1
77127
7 Mar 16
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
EX-3.1
l58kd
13 Jan 16
Apricus Biosciences Announces $10 Million Registered Direct Offering
12:00am
SC 13D
EX-3
sh1ql14hmzzqy2g
23 Feb 15
Beneficial ownership report
12:00am
8-K
EX-3.1
ptibq2j28n5r49z7v be
16 May 13
Entry into a Material Definitive Agreement
12:00am